If you would like to present, start by submitting a proposal. You will need the following: presentation type, short/long descriptions, keywords, focus, themes, and biographical information.
Submit your proposal here.
After we receive your presentation proposal, it moves to the evaluation step. We welcome the submission of proposals at anytime of the year.
All proposals will be reviewed between 24- 48 hr of submission by the Organizing Committee. See proposal deadlines below.
Once your proposal is accepted, you must register before our Program Development team can schedule your presentation.
Advances in Imaging, Drug Discovery in the 4th Dimension, From Molecule to Man: right dose, first time, Innovations in Assay Design, Development and Screening, Innovations in Chemistry, Target Identification and Validation, Prodrug design, Insilco Drug Discovery, Criteria of Target Selection, Computer-Aided Drug Design (CADD), Advancements of In vitro and In vivo studies and Drug Discovery’s Challenges, Fragment based drug discovery
Cancer Targeted Drug Delivery, Precision Medicines, Cardiovascular Drug Discovery and Therapy, CNS Drug Discovery and Therapy, Diabetes and Obesity Drug Discovery &Therapy, Women health drug discovery and therapy and Pulmonary Drug Discovery &Therapy, Drug Abuse, Medical Marijuana
Marketing in a Multichannel World, Customer's Digital Habits, Channel Preferences, New Levels of Targeting, Investment Allocation,
Mobilizing for Mobile Engagement, Metrics to a True Learning Plan
Smart Drug Delivery Systems, Transdermal and Intradermal Drug Delivery Systems, Inhalation Drug Delivery Systems, Routes of Drug Delivery, Ideal drug delivery vehicle, Biomaterials in Drug Delivery, Vaccine Drug Delivery Systems, Peptides and Protein Drug Delivery, Major Challenges in Drug Delivery System, Medical Devices for Drug Delivery
Predictive Analytics, Pre-clinical Discovery, Commercial Models, Customer Lifetime Valuation, Patient-Centricity, Segmentation/Localisation of Pharma, Big Data, Architecture, Informatics, Statistical Approaches for Improving Performance and Compliance
Microbiology in pharmaceutical stability, Deciphering the host-microbe interaction, Real-time monitoring, Complete environmental monitoring program , Quality control strategy on LER, Global electronic intervention logging system
Innovative Therapeutic Studies, Effect of Polymorphism in Pharmaceutical Drug Development, Pharmaceutical Raw Materials, Technical limitations in Drug Development, Difficulties in Regulatory Approvals and Financial constraints in Drug Development
Risk Management, Pre-Clinical Research, Conducts of Clinical Trials, Therapeutic Drug Monitoring and Drug Quantification, Innovations in Clinical Trials, Regulatory affairs & Pharmacovigilance, Bioethics and Quality Regulation, Regulatory Strategies, Regulatory Challenges for Medical Devices, Intellectual Property Rights and Patent Access& Intellectual property& FDA Regulations
Product Testing, Microbiological Safety and Cosmetics, SkinCare and HairCare, Packaging, Fragrance, Animal Testing, Plastic microbeads, Endocrine disruptors, Counterfeit products
Rare diseases, Cell and Gene therapies, Genetic testing, Gene editing, Orphan Drugs Policy, Gene therapy development, Development Trends and Strategies on Orphan Drugs, Challenges in Rare Diseases, Clinical Research and Drug Approvals for Rare Diseases
Nanoparticle synthesis, Nanocarriers, Applications of Pharmaceutical Nanotools, Future Prospects of Pharmaceutical Nanotechnology, Nanomedicine and Drug Delivery, Toxicological assessment of nanomaterials as drugs
Pharmaceutical Manufacturers; processes and difficulties, GMP, GCP and Quality Control, Pharmaceutical industry challenges and the need for global and regional collaboration, GMP Inspections in Pharmaceuticals, Pharmaceutical Analysis and Quality Risk Management (QRM) for pharmaceutical operations
Global labeling tracking system, Inspection readiness strategy, Serialization process, In-house department relationships- In-house efficiency, FDA’s final guidance’s- Naming of Biologics and Biosimilars, Exploiting blockchain technology- Drug Supply Chain Security Act (DSCSA), Pregnancy and Lactation Labeling Rule, Designing combination products (CP)- Bridging divisions between packaging and labeling, Balancing regulatory requirements with brand design, Designing packaging, Tackling language barriers- labels translation, Mastering your packaging- products integrity, FDA’s guidance- DCSAC- Industry standards
Pharmaceutical Formulations Market, Licensing, Manufacturing&Health Economics, Pharma Pricing & Market Access, Global Generic Trends & Global Pharma Market, E-pharma marketing, Post-market surveillance, Generic Drug Market and Contract Manufacturing and Orphan Drugs and Rare Diseases
Biosimilars, Everyday Practice, Manufacturing Pre-Clinical Trials, Biosimilars: The Cancer Patient Perspective
Behavioral Neuropharmacology, Clinical Neuropharmacology, Molecular Neuropharmacology, Neuroendocrinology and Alzheimer’s Disease and Dementia
Vaccines, Gene therapy, Recombinant protein, Stem Cell therapy, Monoclonal Abs and Blood Components, Green chemistry in the pharmaceutical industry, Fate of pharmaceuticals in the environment, Marine Drugs and Natural Products
Nutraceuticals in Disease Prevention and Therapy, Personalized nutrition and medicine, Probiotics and Prebiotics, Nutraceuticals for Weight Management, Dietary Supplements & Functional foods, Nutraceuticals Market- Trends, Skincare Supplements and Cosmetics